Product Images Tranexamic Acid In Sodium Chloride

This text provides information about a Tranexamic Acid in 0.7% Sodium Chloride Injection solution. It contains details on dosage, administration, cautions, storage conditions, and manufacturing information. The solution is intended for intravenous infusion only and each mL contains 10 mg of Tranexamic Acid USP and 7 mg of Sodium Chloride USP. It is crucial to check for any particulate matter in the solution before use. The solution should be stored between 20°C to 25°C with permitted excursions to 15°C to 30°C. The bag and port are not made with natural rubber latex, PVC, or DEHP.*

This is a description of a pharmaceutical product in the form of single-dose containers containing Tranexamic Acid in 0.7% Sodium Chloride Injection. Each mL of the solution contains 10 mg of Tranexamic Acid and 7 mg of Sodium Chloride. It is intended for intravenous infusion only and should be discarded if not used entirely. The product should be stored at temperatures between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is manufactured by GLAND PHARMA LIMITED in India and is sterile, unpreserved, and nonpyrogenic. The dosing and administration information should be followed as per the prescribing information provided.*

This is a description of a pharmaceutical product called Tranexamic Acid in 0.7% Sodium Chloride Injection, presented in a 100 mL Single-Dose Container. Each mL contains 10 mg of Tranexamic Acid USP and 7 mg of Sodium Chloride USP. The solution is for intravenous infusion only. It is important to check for leaks before use and ensure the solution is clear. Additional medications should not be added, and connections must not be used for insertion. The recommended storage temperature is between 20°C to 25°C, with excursions permitted to 15°C to 30°C. This product is sterile, unpreserved, and nonpyrogenic. It is essential to refer to the prescribing information for complete dosing and administration details.*